These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7636859)

  • 21. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
    Fung-Tomc J; Minassian B; Kolek B; Washo T; Huczko E; Bonner D
    J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A; Soltani F; Asadipour A
    Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria.
    Wube AA; Bucar F; Hochfellner C; Blunder M; Bauer R; Hüfner A
    Eur J Med Chem; 2011 Jun; 46(6):2091-101. PubMed ID: 21429630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
    Hayashi K; Takahata M; Kawamura Y; Todo Y
    Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New achievements in the fluoroquinolone problem: possibilities of increasing activity and expansion of the spectrum of action].
    Padeĭskaia EN
    Antibiot Khimioter; 1994 May; 39(5):52-65. PubMed ID: 7857163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antimicrobial activity of some N-alkenyl-2-acylalkylidene-2,3-dihydro-1,3-benzothiazoles.
    Trapani G; Latrofa A; Franco M; Armenise D; Morlacchi F; Liso G
    Arzneimittelforschung; 1994 Aug; 44(8):969-71. PubMed ID: 7945544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
    Bagchi MC; Mills D; Basak SC
    J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine.
    Narendra Sharath Chandra JN; Sadashiva CT; Kavitha CV; Rangappa KS
    Bioorg Med Chem; 2006 Oct; 14(19):6621-7. PubMed ID: 16784863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure elucidation of some 4-substituted benzylidene amino-5-[3(5)-methyl-5(3)-phenyl-1H-1-pyrazolyl]-2,4-dihydro-3H-1,2,4- triazole-3-thione derivatives with their antimicrobial activities.
    Doğan HN; Büyüktimkin S; Rollas S; Yemni E; Cevikbaş A
    Farmaco; 1997; 52(8-9):565-8. PubMed ID: 9507666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antimicrobial activity of some pyrrole derivatives. V: 5-Aryl-3-ethoxycarbonyl-2-(4-substituted piperazino)pyrrole derivatives.
    Cocco MT; Onnis V; Schivo ML; De Logu A
    Farmaco; 1992 Nov; 47(11):1395-405. PubMed ID: 1492903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (Fluorocyclopropyl)quinolones. 2. Synthesis and Stereochemical structure-activity relationships of chiral 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents.
    Kimura Y; Atarashi S; Kawakami K; Sato K; Hayakawa I
    J Med Chem; 1994 Sep; 37(20):3344-52. PubMed ID: 7932562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synergic effect of beta-lapachone and isoniazid on the growth of Mycobacterium fortuitum and Mycobacterium smegmatis.
    Silva JL; Mesquita AR; Ximenes EA
    Mem Inst Oswaldo Cruz; 2009 Jul; 104(4):580-2. PubMed ID: 19722080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
    Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
    J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationships of 7-[3-(1-aminoalkyl)pyrrolidinyl]- and 7-[3-1-aminocycloalkyl)pyrrolidinyl]-quinolone antibacterials.
    Kimura Y; Atarashi S; Takahashi M; Hayakawa I
    Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1442-54. PubMed ID: 7923467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.
    Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Kiechel JR; Remuzon P; Weber A; Oki T; Masuyoshi M; Kessler RE
    J Med Chem; 1990 May; 33(5):1344-52. PubMed ID: 2329555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
    Pathak RB; Chovatia PT; Parekh HH
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.
    Salfinger M; Hohl P; Kafader FM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():55-63. PubMed ID: 3144550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.